Literature DB >> 21993611

Enzymatic cross-linking of human recombinant elastin (HELP) as biomimetic approach in vascular tissue engineering.

Sabrina Bozzini1, Liliana Giuliano, Lina Altomare, Paola Petrini, Antonella Bandiera, Maria Teresa Conconi, Silvia Farè, Maria Cristina Tanzi.   

Abstract

The use of polymers naturally occurring in the extracellular matrix (ECM) is a promising strategy in regenerative medicine. If compared to natural ECM proteins, proteins obtained by recombinant DNA technology have intrinsic advantages including reproducible macromolecular composition, sequence and molecular mass, and overcoming the potential pathogens transmission related to polymers of animal origin. Among ECM-mimicking materials, the family of recombinant elastin-like polymers is proposed for drug delivery applications and for the repair of damaged elastic tissues. This work aims to evaluate the potentiality of a recombinant human elastin-like polypeptide (HELP) as a base material of cross-linked matrices for regenerative medicine. The cross-linking of HELP was accomplished by the insertion of cross-linking sites, glutamine and lysine, in the recombinant polymer and generating ε-(γ-glutamyl) lysine links through the enzyme transglutaminase. The cross-linking efficacy was estimated by infrared spectroscopy. Freeze-dried cross-linked matrices showed swelling ratios in deionized water (≈2500%) with good structural stability up to 24 h. Mechanical compression tests, performed at 37°C in wet conditions, in a frequency sweep mode, indicated a storage modulus of 2/3 kPa, with no significant changes when increasing number of cycles or frequency. These results demonstrate the possibility to obtain mechanically resistant hydrogels via enzymatic crosslinking of HELP. Cytotoxicity tests of cross-linked HELP were performed with human umbilical vein endothelial cells, by use of transwell filter chambers for 1-7 days, or with its extracts in the opportune culture medium for 24 h. In both cases no cytotoxic effects were observed in comparison with the control cultures. On the whole, the results suggest the potentiality of this genetically engineered HELP for regenerative medicine applications, particularly for vascular tissue regeneration.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21993611     DOI: 10.1007/s10856-011-4451-z

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  35 in total

1.  Elastomeric polypentapeptides cross-linked into matrixes and fibers.

Authors:  J Lee; C W Macosko; D W Urry
Journal:  Biomacromolecules       Date:  2001       Impact factor: 6.988

Review 2.  Requirements for growing tissue-engineered vascular grafts.

Authors:  Shannon L Mitchell; Laura E Niklason
Journal:  Cardiovasc Pathol       Date:  2003 Mar-Apr       Impact factor: 2.185

Review 3.  Designing materials for biology and medicine.

Authors:  Robert Langer; David A Tirrell
Journal:  Nature       Date:  2004-04-01       Impact factor: 49.962

Review 4.  Scaffolds in tissue engineering of blood vessels.

Authors:  Divya Pankajakshan; Devendra K Agrawal
Journal:  Can J Physiol Pharmacol       Date:  2010-09       Impact factor: 2.273

5.  Chemical synthesis of cross-linked poly(KGGVG), an elastin-like biopolymer.

Authors:  M Martino; A M Tamburro
Journal:  Biopolymers       Date:  2001-07       Impact factor: 2.505

6.  Design and bioproduction of a recombinant multi(bio)functional elastin-like protein polymer containing cell adhesion sequences for tissue engineering purposes.

Authors:  Alessandra Girotti; Javier Reguera; José Carlos Rodríguez-Cabello; Francisco Javier Arias; Matilde Alonso; Ana Matestera
Journal:  J Mater Sci Mater Med       Date:  2004-04       Impact factor: 3.896

7.  Cross-linked open-pore elastic hydrogels based on tropoelastin, elastin and high pressure CO2.

Authors:  Nasim Annabi; Suzanne M Mithieux; Anthony S Weiss; Fariba Dehghani
Journal:  Biomaterials       Date:  2009-12-06       Impact factor: 12.479

8.  Human tissue-engineered blood vessels for adult arterial revascularization.

Authors:  Nicolas L'Heureux; Nathalie Dusserre; Gerhardt Konig; Braden Victor; Paul Keire; Thomas N Wight; Nicolas A F Chronos; Andrew E Kyles; Clare R Gregory; Grant Hoyt; Robert C Robbins; Todd N McAllister
Journal:  Nat Med       Date:  2006-02-19       Impact factor: 53.440

Review 9.  Smart and genetically engineered biomaterials and drug delivery systems.

Authors:  Jindrich Kopecek
Journal:  Eur J Pharm Sci       Date:  2003-09       Impact factor: 4.384

10.  Recombinant human elastin polypeptides self-assemble into biomaterials with elastin-like properties.

Authors:  Catherine M Bellingham; Margo A Lillie; John M Gosline; Glenda M Wright; Barry C Starcher; Allen J Bailey; Kimberly A Woodhouse; Fred W Keeley
Journal:  Biopolymers       Date:  2003-12       Impact factor: 2.505

View more
  4 in total

1.  Advancing biomaterials of human origin for tissue engineering.

Authors:  Fa-Ming Chen; Xiaohua Liu
Journal:  Prog Polym Sci       Date:  2015-03-28       Impact factor: 29.190

Review 2.  Fabricated Elastin.

Authors:  Behnaz Aghaei-Ghareh-Bolagh; Edwin P Brackenreg; Matti A Hiob; Pearl Lee; Giselle C Yeo; Anthony S Weiss
Journal:  Adv Healthc Mater       Date:  2015-03-13       Impact factor: 9.933

Review 3.  Biocatalysis by Transglutaminases: A Review of Biotechnological Applications.

Authors:  Maria Pia Savoca; Elisa Tonoli; Adeola G Atobatele; Elisabetta A M Verderio
Journal:  Micromachines (Basel)       Date:  2018-10-31       Impact factor: 2.891

4.  Application of elastin-mimetic recombinant proteins in chemotherapeutics delivery, cellular engineering, and regenerative medicine.

Authors:  Won Bae Jeon
Journal:  Bioengineered       Date:  2013-03-08       Impact factor: 3.269

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.